← All organizations

Braeburn Pharmaceuticals

For profitWebsite ↗

Also known as: BRAEBURN | BRAEBURN PHARMA INC

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

Last known activity

May 23, 2023

Timeline

2010s

Jan 1, 2012
Braeburn Pharmaceuticals— Founded
Dec 21, 2018
buprenorphine— NDA Secondary Org

2020s

May 23, 2023
buprenorphine— Marketing Organization

Drugs by trial phase (4 distinct, 14 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

buprenorphine

Recent trials (15)

NCT02946073Lead sponsorPhase 3Oct 1, 2016
NCT02824666Lead sponsorPhase 1Jun 1, 2016
NCT02773576Lead sponsorPhase 3Apr 1, 2016
NCT02651584Lead sponsorPhase 3Dec 1, 2015
NCT02651584Study chairPhase 3Dec 1, 2015
NCT02672111Lead sponsorN/ANov 1, 2015
NCT02658357Lead sponsorPhase 2Oct 1, 2015
NCT02611752Lead sponsorPhase 2Oct 1, 2015
NCT02710526Lead sponsorPhase 2Feb 1, 2015
NCT02180659Lead sponsorPhase 3Jul 1, 2014
NCT01262261Lead sponsorPhase 3Nov 1, 2010
NCT00768482Lead sponsorPhase 3Sep 1, 2008
NCT00772785Lead sponsorPhase 3Sep 1, 2008
NCT00630201Lead sponsorPhase 3Oct 1, 2007
NCT00447564Lead sponsorPhase 3Oct 1, 2006

Details

Founded: Plymouth Meeting, PA, US Jan 1, 2012
Last known activity: May 23, 2023